Philips launches NightBalance for OSA patientsNovember 15, 2019
Royal Philips has launched NightBalance, a prescription sleep position therapy device designed for patients with positional obstructive sleep apnea (OSA).
A mask-free alternative to existing positional OSA treatments, NightBalance is a clinically validated positional therapy that uses gentle vibrations to encourage users to alter their sleeping positions to help prevent apneas.
The new positional OSA technology features wireless connectivity and a mobile app that monitors product use and provides patients and physicians with access to data via a cloud-based system.
Multiple clinical studies have found that the system offers an effective form of non-invasive treatment for positional OSA patients.
A recent study funded by Philips found NightBalance to be a non-inferior treatment to continuous positive airway pressure (CPAP) and demonstrate high adherence rates among positional OSA patients.
Data showed that patients with positional OSA felt the device was easier to use, easier to adjust to and more comfortable than other PAP therapy methods.
Additionally, patients who used the sleep position treatment used the device for greater lengths of time compared to PAP therapy, with 74 percent of patients reported using NightBalance for more than four hours, compared to 64.9 percent.